Multiple Myeloma Posts Page 2 on Medivizor
Navigation Menu

Multiple Myeloma Posts on Medivizor

Weekly carfilzomib, cyclophosphamide, and dexamethasone in multiple myeloma

Posted by on Jan 26, 2018 in Multiple Myeloma | 0 comments

In a nutshell This paper studied the outcome of weekly carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma who cannot be treated with transplant. The authors concluded that this combination was effective in these patients. Some background Multiple myeloma is a cancer of the plasma cells of the blood....

Read More

What is Neutropenia?

What is Neutropenia?

Posted by on Jan 21, 2018 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 1 comment

There are 1.6 million people diagnosed with cancer in the US each year. Of these, 650,000 receive chemotherapy. Did you know that 60,000 people a year are hospitalized for neutropenia, a common side effect of chemotherapy? One in fourteen die because of it. Of the 650,000 receiving chemotherapy, 104,000 are not aware of neutropenia and 52,000 don’t...

Read More

Emergencies and Illness

Emergencies and Illness

Posted by on Jan 17, 2018 in Blog, Breast cancer, Colorectal cancer, Coronary artery disease, Diabetes mellitus, Hodgkin's lymphoma, Hypertension, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Prostate cancer | 1 comment

After three hurricanes, flooding, fires and mudslides, and now severe cold and snow in the Deep South and throughout the country, the US has had its share of emergencies. Are you prepared? For people who rely on oxygen, who are on dialysis, have diabetes or other serious conditions, it is time to think about putting together some of the essentials.  What...

Read More

Side effects of treatment in multiple myeloma

Posted by on Jan 12, 2018 in Multiple Myeloma | 0 comments

In a nutshell This paper reviewed the side effects of drugs used in the treatment of multiple myeloma.  Some background Treatment for multiple myeloma includes different groups of medications. Immunomodulatory drugs work by changing the function of the immune systems. Proteasome inhibitors work by blocking the breakdown of proteins that are...

Read More

CAR T-Cells and HIV: What’s the Connection?

CAR T-Cells and HIV: What’s the Connection?

Posted by on Jan 5, 2018 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 1 comment

It has taken decades of work for researchers to find ways to activate the immune system to treat cancer (what we now call immuno-oncology or I-O). Much of that work has been poorly funded. Largely, it has been the result of researchers getting experience in other disciplines (like infectious disease) and then transferring that expertise to oncology...

Read More

Coping with a Myeloma Diagnosis: Regaining Emotional and Psychological Control

Posted by on Jan 3, 2018 in Multiple Myeloma | 0 comments

Video information: The emotional and psychological battle from a myeloma diagnosis doesn’t have to be fought alone. Tune in to hear Dr. Frits van Rhee and Kristen Carter discuss how to take control of mental health, which is a vital factor to living well throughout the journey of cancer, and provide supportive resources available to help...

Read More

Daratumumab plus bortezomib, melphalan, and prednisone for newly diagnosed myeloma

Posted by on Dec 30, 2017 in Multiple Myeloma | 0 comments

In a nutshell This paper studied the effect of daratumumab together with bortezomib, melphalan, and prednisone in patients with newly diagnosed multiple myeloma. The study found that the addition of daratumumab improved survival.  Some background Multiple myeloma is a cancer of the plasma cells of the blood. Daratumumab (Darzalex) is a drug...

Read More

Survival after relapse between autologous/allogeneic HCT and autologous/autologous HCT

Posted by on Dec 30, 2017 in Multiple Myeloma | 0 comments

In a nutshell This paper compared survival between autologous-allogeneic (auto/allo) and autologous-autologous (auto/auto) hematopoietic cell transplantation (HCT) in patients with relapsed multiple myeloma. This study concluded that survival after relapse was better in those who received auto/allo HCT compared to auto/auto HCT.  Some background...

Read More